Keefe, Bruyette & Woods reiterates outperform rating on Bowhead stock

Keefe, Bruyette & Woods reiterated its outperform rating on Bowhead Specialty Holdings (BOW) with a $45 price target, projecting continued profitability and mid-teens return on equity driven by strong casualty pricing and the Baleen platform. This follows Bowhead's Q1 2025 results showing a 26% increase in gross written premiums to $175 million and adjusted net income of $11.5 million, although the stock saw a premarket decline of 2.2% despite the positive results. KBW's analysis assumes a favorable casualty environment and anticipates solid revenue growth, expecting Bowhead's insulation from pre-2020 reserve concerns to further boost shares.

Analysis

Keefe, Bruyette & Woods (KBW) has reaffirmed its 'outperform' rating and $45.00 price target for Bowhead Specialty Holdings (NYSE: BOW), citing confidence in sustained mid-teens return on equity (ROE) driven by strong casualty pricing and profitable premium growth. This growth is increasingly supported by Baleen, Bowhead's technology-based small-account E&S platform. KBW projects earnings per share of $1.65 for 2025, $2.05 for 2026, and has introduced a 2027 estimate of $2.40, with the price target representing 22.0 times the firm's 2026 estimate, compared to the current trading P/E of 29x. Bowhead's recent performance includes a 14% ROE and 45% revenue growth over the last twelve months. The company's Q1 2025 results were robust, with a 26% increase in gross written premiums to $175 million and adjusted net income of $11.5 million ($0.34 per diluted share), primarily driven by the casualty division. Net investment income also saw a significant 64% year-over-year increase to $12.6 million. Despite these positive figures, BOW's stock experienced a 2.2% premarket decline, suggesting some investor apprehension. Bowhead anticipates 20% annual premium growth, underpinned by its Baleen platform and distribution network expansion. KBW highlights Bowhead's conservative initial accident-year loss picks, potential for reserve releases, and insulation from pre-2020 accident year reserve adequacy concerns as positive factors. The company maintains a combined ratio of 97.3%, with a loss ratio of 66.9% and an expense ratio of 30.4%.

Key Decisions for Investors

• Investors should note the strong endorsement from Keefe, Bruyette & Woods, particularly their confidence in sustained mid-teens ROE and the growth potential from the Baleen platform, alongside robust Q1 2025 financial results.
• Consider the current valuation, with a P/E of 29x, against KBW's price target based on a 22.0x multiple of 2026 earnings, and weigh this against the recent premarket stock decline which may indicate market sensitivity or profit-taking.
• Monitor the ongoing casualty pricing environment, the execution of the Baleen platform's expansion, and Bowhead's ability to maintain disciplined underwriting (as indicated by its combined ratio and loss picks) to achieve its projected 20% annual premium growth and EPS targets.